Drug · DIN 02377098
DIVIGEL
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since April 23, 2015; first marketed September 27, 2012.
- Drug Identification Number (DIN)
- 02377098
- Company (DIN owner)
- Teva Canada LimitedToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Gel
- Route
- Transdermal
- Therapeutic class (ATC)
- Estradiol G03CA03
- Class
- Human
- Record last updated
- June 25, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ESTRADIOL | 0.1 % |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 10, 2014: NOC 15243New Drug Submission (NDS) · Transfer of drug identification number
- December 1, 2011: NOC 12822New Drug Submission (NDS)
Other DINs named DIVIGEL
- DIN 02424835 · Marketed
- DIN 02424843 · Marketed
- DIN 02424924 · Marketed